JAZZ
NASDAQ
IE
Jazz Pharmaceuticals plc - Ordinary Shares
$186,95
▼ $-1,32
(-0,70%)
Vol. 696K
7
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$10.3B
ROE
-9,3%
Margine
-8,9%
D/E
135,42
Beta
0,27
52W
$95–$183
Consenso Wall Street
23 analisti · Apr 20268
Acquisto forte
13
Compra
2
Mantieni
0
Vendi
0
Vendita forte
91,3%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 25,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $6,65 | $6,64 | $-0,01 |
| Set 2025 | $6,04 | $8,13 | +$2,09 |
| Giu 2025 | $-7,76 | $-8,25 | $-0,49 |
| Mar 2025 | $4,75 | $1,68 | $-3,07 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $1.1B | $897.8M | $1.0B | $1.1B | $1.2B |
| Utile netto | — | $191.1M | -$92.5M | -$718.5M | $251.4M | $203.5M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -10.0% | -10.0% | -10.0% | -10.0% | -9.2% | -9.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -68.7% | -9.9% | -9.9% | -9.9% | -8.9% | -8.9% |
| Gross Margin | 88.9% | 88.7% | 88.7% | 88.7% | 88.5% | 88.5% |
| D/E Ratio | 144.73 | 144.73 | 144.73 | 144.73 | 135.42 | 135.42 |
| Current Ratio | 1.62 | 1.62 | 1.62 | 1.62 | 1.65 | 1.65 |
Rapporti chiave
ROA (TTM)
-3,2%
P/S (TTM)
2,48
P/B
1,8
EPS (TTM)
$-6,07
CF/Share
$10,05
Crescita ricavi 3A
+9,6%
52W High
$182,99
52W Low
$95,49
$95,49
Intervallo 52 settimane
$182,99
Salute finanziaria
Flusso di cassa libero
$292.3M
Debito netto
$4.0B
Liquidità
$1.4B
Debito totale
$5.4B
Aggiornato al Dic 31, 2025
Як JAZZ виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Large-cap Pharmaceuticals ($10B+) · 7 компаній
Оцінка JAZZ vs аналоги Pharmaceuticals
P/E
—
▼
0%
sotto
peer
(18,2)
vs Peer
vs Settore
Sopravvalutato
P/S
2,5
▼
21%
sotto
peer
(3,2)
vs Peer
vs Settore
Più costoso
P/B
1,8
▼
9%
sotto
peer
(2,0)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
—
▼
0%
sotto
peer
(3,1%)
vs Peer
vs Settore
In linea
Прибутковість JAZZ vs аналоги Pharmaceuticals
ROE
-9,3%
▼
180%
sotto
peer
(11,6%)
vs Peer
vs Settore
Debole
Net margin
-8,9%
▼
148%
sotto
peer
(18,4%)
vs Peer
vs Settore
Debole
Валова маржа
88,5%
▲
22%
sopra
peer
(72,3%)
vs Peer
vs Settore
Sotto media
ROA
-3,2%
▼
177%
sotto
peer
(4,2%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя JAZZ vs аналоги Pharmaceuticals
D/E ratio
135,4
▲
90%
sopra
peer
(71,1)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,7
▲
0%
sopra
peer
(1,7)
vs Peer
vs Settore
In linea
Beta
0,3
▼
69%
sotto
peer
(0,9)
vs Peer
vs Settore
Più volatile
Радар фундаменталів JAZZ
JAZZ
Mediana peer
Industria
JAZZ прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
JAZZ vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
CARR PATRICIA
Officer · Mar 09
1287 shs
COZADD BRUCE C
Director · Mar 03
6000 shs
RIEDEL NORBERT G
Director · Feb 27
3415 shs
CARR PATRICIA
Officer · Feb 27
2370 shs
RIEDEL NORBERT G
Director · Feb 27
3415 shs
PATIL NEENA M
Officer · Feb 26
51000 shs
HENDERSON MARY ELIZABETH
Officer · Feb 26
5343 shs
PATIL NEENA M
Officer · Feb 26
55600 shs
CARR PATRICIA
Officer · Feb 26
2223 shs
PEARCE SAMANTHA
Officer · Feb 26
9782 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 31,05%Vanguard Group Inc
9,61%
$1.1B
Blackrock Inc.
8,86%
$1.0B
Capital World Investors
4,33%
$491.4M
Dimensional Fund Advisors LP
4,26%
$483.4M
LSV Asset Management
3,99%
$452.6M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora